$CTMX 4 SEC Filings

Filed On	Filing
05 Aug 2026	Form 4: Carvajal Alejandra, Chief Legal Officer Received 100,000 shares as a grant or award · Granted 450,000 Stock Option (Right to Buy)
30 Jul 2026	Form 4: Fuchs Charles S., Director Granted 118,000 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Su Zhen, Director Granted 59,000 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Young Matthew P., Director Granted 59,000 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Mohindru Mani, Director Granted 59,000 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Meyers James R, Director Granted 59,000 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Gilbert Halley E, Director Granted 59,000 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Ashworth Alan, Director Granted 59,000 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Jones Elaine V, Director Granted 59,000 Stock Option (Right to Buy)
17 Jun 2026	Form 4: Ogden Christopher, Chief Financial Officer Sold 1,624 shares ($4.95K)
19 Mar 2026	Form 4: Chu Yu-Waye, Chief Medical Officer Sold 21,279 shares ($137K)
19 Mar 2026	Form 4: McCarthy Sean A., Director Sold 118,969 shares ($764K)
19 Mar 2026	Form 4: Belvin Marcia, SVP, Chief Scientific Officer Sold 31,492 shares ($202K)
19 Mar 2026	Form 4: Ogden Christopher, Chief Financial Officer Sold 19,323 shares ($124K)
04 Feb 2026	Form 4: Lester Rachael, Chief Business Officer Received 20,000 shares as a grant or award · Granted 50,000 Stock Option (Right to Buy) · Granted 50,000 Performance Stock Units (PSUs)
04 Feb 2026	Form 4: Chu Yu-Waye, Chief Medical Officer Received 75,000 shares as a grant or award · Granted 300,000 Stock Option (Right to Buy)
04 Feb 2026	Form 4: Belvin Marcia, SVP, Chief Scientific Officer Received 60,000 shares as a grant or award · Granted 250,000 Stock Option (Right to Buy)
04 Feb 2026	Form 4: Ogden Christopher, Chief Financial Officer Received 90,000 shares as a grant or award · Granted 325,000 Stock Option (Right to Buy)
04 Feb 2026	Form 4: McCarthy Sean A., Director Received 210,000 shares as a grant or award · Granted 980,000 Stock Option (Right to Buy)
10 Nov 2025	Form 4: McCarthy Sean A., Director Sold 101,793 shares ($462K)

Comments